| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 7e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 9e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |